Envista Holdings Co. (NYSE:NVST - Get Free Report)'s share price hit a new 52-week low during trading on Thursday . The company traded as low as $14.22 and last traded at $16.41, with a volume of 4266296 shares. The stock had previously closed at $14.76.
Wall Street Analyst Weigh In
Several analysts have issued reports on the company. Needham & Company LLC reissued a "hold" rating on shares of Envista in a report on Thursday, March 6th. Wells Fargo & Company set a $19.00 target price on shares of Envista in a report on Saturday, March 8th. UBS Group dropped their price target on shares of Envista from $23.00 to $21.00 and set a "neutral" rating for the company in a research report on Monday, March 10th. New Street Research set a $19.00 price target on Envista in a research note on Thursday, March 6th. Finally, Piper Sandler boosted their price objective on Envista from $17.00 to $18.00 and gave the company a "neutral" rating in a research report on Monday, February 3rd. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat, Envista currently has an average rating of "Hold" and an average price target of $20.18.
Get Our Latest Research Report on Envista
Envista Stock Performance
The company has a quick ratio of 1.76, a current ratio of 2.04 and a debt-to-equity ratio of 0.44. The firm has a 50 day moving average of $18.31 and a 200-day moving average of $19.33. The company has a market cap of $2.65 billion, a P/E ratio of -2.37, a PEG ratio of 1.27 and a beta of 1.12.
Envista (NYSE:NVST - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.01. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. As a group, sell-side analysts anticipate that Envista Holdings Co. will post 1 EPS for the current fiscal year.
Institutional Trading of Envista
A number of hedge funds have recently bought and sold shares of the stock. SG Americas Securities LLC raised its position in shares of Envista by 594.3% in the 1st quarter. SG Americas Securities LLC now owns 108,509 shares of the company's stock worth $1,873,000 after acquiring an additional 92,880 shares in the last quarter. UMB Bank n.a. lifted its position in shares of Envista by 214.4% during the first quarter. UMB Bank n.a. now owns 2,094 shares of the company's stock valued at $36,000 after buying an additional 1,428 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of Envista by 1,338.3% in the 1st quarter. GAMMA Investing LLC now owns 33,139 shares of the company's stock valued at $572,000 after buying an additional 30,835 shares in the last quarter. First Hawaiian Bank grew its position in shares of Envista by 47.4% in the 1st quarter. First Hawaiian Bank now owns 47,597 shares of the company's stock worth $822,000 after buying an additional 15,312 shares during the last quarter. Finally, Polar Asset Management Partners Inc. raised its stake in shares of Envista by 27.9% during the 4th quarter. Polar Asset Management Partners Inc. now owns 1,914,799 shares of the company's stock worth $36,936,000 after acquiring an additional 417,549 shares in the last quarter.
Envista Company Profile
(
Get Free Report)
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Featured Stories
Before you consider Envista, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.
While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
